Freedom Leaf

JULY 20, 2017

A study published by the Journal of Addiction Research and Therapy on Feb. They reported that subjects’ cannabis use history was correlated with a “small, yet consistent increase in odds” for hypertension, obesity and other risk factors. MetS risk factors are linked to cardiovascular diseases like heart attacks and strokes.

Blood Pressure 43

Blood Pressure Research and Development Clinical Trials History 43

Cannabis Law Report

NOVEMBER 15, 2021

PCR-produced LinearDNA serves as a pure, fast, and flexible alternative to plasmid DNA (pDNA) in the manufacture of cell and gene therapies (CGTs) and nucleic acid vaccines. CRO orders typically provide a means to evaluate LinearDNA within a customer’s preclinical development program. News release. FDA website. January 15, 2019. 2021.08.006.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

DECEMBER 15, 2021

The signing of the MoU follows the joint presentation of initial data by the companies at an American Apparel and Footwear Association event that describes a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using cotton genomics with affirmation by IA.

Supply Chain 52

Supply Chain Therapy Research and Development Events 52

MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. Their website is a fount of information that indicates high patient satisfaction (including testimonials and data on clinical trials). Downtown Pain Physicians of Brooklyn.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Cannabis Law Report

SEPTEMBER 8, 2021

All the data points associated to tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform has three technology pillars (Tag, Test, Track), which allows raw materials and products to be tagged with a unique molecular identifier.

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 3, 2021

Applied DNA is also the manufacturer of the EUA-authorized Linea™ COVID-19 Assay Kit. Forward-looking statements describe Applied DNA’s future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

JUNE 2, 2021

Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company’s deep expertise in DNA.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

SEPTEMBER 2, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

JANUARY 18, 2022

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Research and Development 52

Research and Development Therapy Supply Chain Collective 52

Cannabis Law Report

SEPTEMBER 27, 2021

All the data points associated with tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform has three technology pillars (Tag, Test, Track), which allows raw materials and products to be tagged with a unique molecular identifier.

Supply Chain 52

Supply Chain Therapy Research and Development Pharmaceutical 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Training Curriculum Recommendations.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

OCTOBER 12, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 9, 2021

Established history of providing FDA-approved ketamine infusion services: The management team at KWC has been in business for 6 years expanding services throughout the United States. Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 10 clinic locations serving communities across eight states.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Info

MARCH 2, 2019

It is only in recent human history, that this mighty herb fell victim to human greed and was bound into the chains of prohibition. Cannabis has been shown in several studies to successfully treat seizures , completely eradicating them in some cases. STUDIES.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

DECEMBER 21, 2021

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. Workforce – Analyst data reveals that the employment rate at 4.6% (Oct.

Research and Development 52

Research and Development Supply Chain Data Business 52

The Joint Blog

APRIL 4, 2019

According to a NORML news release, authors reported that patients with a history of cannabis use possessed fewer complications and experienced better clinical outcomes as compared to abstainers. METHODS: We used data from the Healthcare Cost and Utilization Project-National Inpatient Sample.

Digestion 42

Digestion Marijuana Patients Therapy 42

Greencamp

AUGUST 16, 2018

Brief history of ALS. Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease.”. Carter GT, Bedlack R, Hardiman O, Pastula DM; ALSUntangled No.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JULY 24, 2022

analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 Data Bridge Market Research , (last viewed 13 July 2022). [2] billion by 2029. [1]

Research and Development 52

Research and Development Legalization Treatment Patients 52

StrainConnect

MARCH 9, 2019

A Quick History Lesson. Now that we got our vocab lesson in, let’s slide into history class. Therefore, the molecules can easily be integrated into our nervous system, resulting in cannabis acting as a form of therapy. Cannabinoid therapy is connected to the part of the biological process where the brain and mind meet.

Research and Development 42

Research and Development Cannabinoids Sativa THC 42

Cannabis Law Report

SEPTEMBER 20, 2021

Established history of providing ketamine infusion services: The management team at KWC has been in ?business business for 6 years expanding services throughout the United States. Management expertise: The acquisition of KWC will add a team of 60+ medical professionals and ?

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

JULY 30, 2019

In the 2018 issue of the INvisibleProject.org ‘s annual “ Medical Cannabis: One Therapy, Many Journeys ,” Ellen Lenox Smith believes it is imperative for society to understand the following fact about medical cannabis: “ it is an indigenous plant found in nature that is non-invasive and safe. Pain Foundation.

Marijuana 40

Marijuana Education Patients Research and Development 40

The Cannigma

AUGUST 5, 2022

2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” Depression and psychedelics. Who could you be if you felt better?

Treatment 138

Treatment Research and Development Therapy Digestion 138

The Cannigma

JULY 5, 2023

1 There are many treatments available for insomnia, including over-the-counter and prescription sleeping pills, Cognitive Behavior Therapy (CBT), lifestyle and sleep hygiene changes. Unsurprisingly, there’s a fair bit of interest in treating insomnia with cannabis given the long history of people using it for better sleep.

Sleep 52

Sleep THC CBD Blood Pressure 52

Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0 Assay for COVID-19 testing to support New York State-based safeCircle™ clients for the diagnostic testing of COVID-19.

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. At 36, MAPS is now older than I was when I started MAPS at age 32.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JANUARY 21, 2022

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

NOVEMBER 5, 2021

CLEARED4 captures, validates and matches user’s information to real-time health data including health surveys, temperature screening, integrated COVID-19 test results and vaccination status. Applied DNA has also established a COVID-19 diagnostic and testing offering that is grounded in the Company’s deep expertise in DNA.

Compliance 52

Compliance Compliance Research and Development Therapy 52

The Cannigma

APRIL 8, 2021

It’s not a targeted therapy, that’s why it’s so good at symptom relief, but it hasn’t fix much of anything. CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. They’re not taking good med histories.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

JANUARY 28, 2022

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Therapy 52

Therapy Research and Development Supply Chain Events 52

SMPL

AUGUST 15, 2019

National Data, State Laws. In the latest study, economists from Massachusetts and Colorado examined mortality data from the Centers for Disease Control (1999 through 2017), and cross-checked that against data on the legal history of cannabis in each state.

Dispensary 40

Dispensary Data Access Patients 40

Cannabis Law Report

OCTOBER 25, 2021

Applied DNA has also established a COVID-19 diagnostic and testing offering that is grounded in the Company’s deep expertise in DNA.

Research and Development 52

Research and Development Therapy Collective Treatment 52

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. At the same time, the outlook on cannabis research data is largely positive. It also has an extensive and diverse history of medicinal use.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. doctors, dentists, radiographers, nurses, pharmacists and psychologists) for patients who do not fit the Category A definition and where the UTG is not deemed to have an ‘established history of use’ Approval from the TGA is required before the UTG may be accessed.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Green Relief

MAY 13, 2018

government-sponsored scientific research – and to extensive anecdotal accounts from medical marijuana patients – which highlight the potential of cannabinoid-based therapies for TBI. Hypothermia is typically the go-to therapy for treating newborn infants after a stroke. Complementary Therapies for TBI. Ancient therapies.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

government-sponsored scientific research – and to extensive anecdotal accounts from medical marijuana patients – which highlight the potential of cannabinoid-based therapies for TBI. Hypothermia is typically the go-to therapy for treating newborn infants after a stroke. Complementary Therapies for TBI. Ancient therapies.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40